Clinical trial
A Phase II Study of Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma
NCT01700946 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma
- Lead sponsor
- St. Jude Children's Research Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 15, 2013
- Completion date
- July 24, 2021
- Enrollment
- 80 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent b-cell childhood acute lymphoblastic leukemia, recurrent childhood b-lymphoblastic lymphoma